+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Empty Capsules Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797939
Global Empty Capsules Market Report and Forecast 2023-2031
Global Empty Capsules Market Outlook
The global empty capsules market value was USD 2.27 billion in 2022, driven by the increasing demand for capsule-based pharmaceutical and nutraceutical products across the globe. The market size is anticipated to grow at a CAGR of 7% during the forecast period of 2023-2031 to achieve a value of USD 4.17 billion by 2031.

Empty Capsules Introduction

Empty capsules are an essential component in the pharmaceutical and nutraceutical industries, providing a convenient and effective means of administering medication and dietary supplements. They are typically made from gelatin, derived from animal collagen, or hydroxypropyl methylcellulose (HPMC), a plant-based alternative, and come in various sizes and colors to accommodate different formulations and dosages. The global empty capsules market encompasses both gelatin capsules and non-gelatin capsules, catering to a wide range of applications, including traditional drugs, herbal medicines, and dietary supplements.

Empty Capsules Market Scenario

The global empty capsules market has experienced significant growth in recent years, driven by factors such as the increasing demand for capsule-based pharmaceutical and nutraceutical products, advancements in capsule manufacturing technologies, and a growing preference for vegetarian capsules.

North America: The largest market for empty capsules, driven by factors such as the advanced pharmaceutical and nutraceutical industries, a high prevalence of chronic diseases, and the presence of major capsule manufacturers.

Europe: The second-largest market, with increasing demand for empty capsules due to a growing aging population, a supportive regulatory framework, and an expanding nutraceutical sector.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.

Empty Capsules Market Segmentations

Market Breakup by Type

  • Gelatin Capsules
  • Non-Gelatin Capsules

Market Breakup by Functionality

  • Immediate-Release Capsules
  • Sustained-Release Capsules
  • Delayed-Release Capsules

Market Breakup by Application

  • Antibiotic
  • Antibacterial Drugs
  • Dietary Supplements
  • Antacid
  • Antiflatulent Preparations
  • Antianemic Preparations
  • Anti-Inflammatory Drugs
  • Cardiovascular Therapy Drugs
  • Cough and Cold Drugs
  • Others

Market Breakup by End User

  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetic Industry and Research Laboratories

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Empty Capsules Market

Some key trends of the market are as follows:
  • Growing demand for capsule-based pharmaceutical and nutraceutical products: The increasing prevalence of chronic diseases and a growing awareness of the benefits of dietary supplements have contributed to the rising demand for capsule-based products, driving the growth of the empty capsules market
  • Advancements in capsule manufacturing technologies: The development of new technologies, such as capsule filling machines and capsule coating systems, has improved the efficiency and quality of capsule manufacturing, contributing to market expansion
  • Increasing preference for vegetarian capsules: A growing number of consumers are opting for plant-based alternatives to traditional gelatin capsules due to dietary restrictions, religious beliefs, or concerns about animal-derived products, driving the demand for non-gelatin capsules

Empty Capsules Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • ACG
  • CapsCanada
  • Bright Pharma Caps
  • Lonza
  • SavoiurCaps
  • Comed Chemicals Limited
  • NATURAL CAPSULES LIMITED
  • Wuhan Carma Technology Co., Ltd
  • Goerlich Pharma GmbH
  • NecLife Lifesciences Ltd
  • HealthCaps India Ltd
  • Erawat Pharma Limited
  • QUALICAPS
  • SUHEUNG co., ltd
  • Fortcaps
  • SNAIL PHARMA INDUSTRY
  • Roxlor
  • Sunil Healthcare Limited
  • H & CARE Incorp
  • SHAOXING KANGKE CAPSULE CO., LTD

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Empty Capsules Market Overview
3.1 Global Empty Capsules Market Historical Value (2016-2022)
3.2 Global Empty Capsules Market Forecast Value (2023-2031)
4 Global Empty Capsules Market Landscape
4.1 Global Empty Capsules Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Empty Capsules Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications
5 Global Empty Capsules Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Empty Capsules Market Segmentation
6.1 Global Empty Capsules Market, by Type
6.1.1 Market Overview
6.1.2 Gelatin Capsules
6.1.3 Non-Gelatin Capsules
6.2 Global Empty Capsules Market, by Functionality
6.2.1 Market Overview
6.2.2 Immediate-Release Capsules
6.2.3 Sustained-Release Capsules
6.2.4 Delayed-Release Capsules
6.3 Global Empty Capsules Market, by Application
6.3.1 Market Overview
6.3.2 Antibiotic
6.3.3 Antibacterial Drugs
6.3.4 Dietary Supplements
6.3.5 Antacid
6.3.6 Antiflatulent Preparations
6.3.7 Antianemic Preparations
6.3.8 Anti-Inflammatory Drugs
6.3.9 Cardiovascular Therapy Drugs
6.3.10 Cough and Cold Drugs
6.3.11 Others
6.4 Global Empty Capsules Market, by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical Industry
6.4.3 Nutraceutical Industry
6.4.4 Cosmetic Industry and Research Laboratories
6.5 Global Empty Capsules Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Empty Capsules Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Empty Capsules Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Empty Capsules Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Empty Capsules Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Empty Capsules Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 ACG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 CapsCanada
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bright Pharma Caps
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Lonza
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 SavoiurCaps
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Comed Chemicals Limited.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 NATURAL CAPSULES LIMITED
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Wuhan Carma Technology Co., Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Goerlich Pharma GmbH
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 NecLife Lifesciences Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 HealthCaps India Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Erawat Pharma Limited.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 QUALICAPS
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 SUHEUNG co., ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Fortcaps
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 SNAIL PHARMA INDUSTRY
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Roxlor
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Sunil Healthcare Limited
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 H & CARE Incorp
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 SHAOXING KANGKE CAPSULE CO., LTD
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
18 Global Dental Laboratories Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Pricing Models and Strategies (Additional Insight)
21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark

Companies Mentioned

  • Acg
  • Capscanada
  • Bright Pharma Caps
  • Lonza
  • Savoiurcaps
  • Comed Chemicals Limited.
  • Natural Capsules Limited
  • Wuhan Carma Technology Co. Ltd.
  • Goerlich Pharma GmbH
  • Neclife Lifesciences Ltd
  • Healthcaps India Ltd.
  • Erawat Pharma Limited.
  • Qualicaps
  • Suheung Co. Ltd.
  • Fortcaps
  • Snail Pharma Industry
  • Roxlor
  • Sunil Healthcare Limited
  • H & Care Incorp
  • Shaoxing Kangke Capsule Co. Ltd

Methodology

Loading
LOADING...

Table Information